Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, Bovet P, Bush AI, Conus P, Copolov D, Fornari E, Meuli R, Solida A, Vianin P, Cuénod M, Buclin T, Do KQ.
Lavoie S, et al.
Neuropsychopharmacology. 2008 Aug;33(9):2187-99. doi: 10.1038/sj.npp.1301624. Epub 2007 Nov 14.
Neuropsychopharmacology. 2008.
PMID: 18004285
Clinical Trial.